Published in PLoS One on December 30, 2013
Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3β-related T regulatory cell insufficiency. PLoS One (2014) 0.79
Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract. Front Med (Lausanne) (2014) 0.76
Mechanical stretch regulates microRNA expression profile via NF-κB activation in C2C12 myoblasts. Mol Med Rep (2016) 0.75
OM-85 is an immunomodulator of interferon-β production and inflammasome activity. Sci Rep (2017) 0.75
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity (2003) 4.93
The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev (2003) 3.96
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood (2003) 2.57
A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J (2006) 2.41
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med (1997) 2.04
Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med (2011) 1.87
Immunoglobulin responses at the mucosal interface. Annu Rev Immunol (2011) 1.82
Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med (2008) 1.67
Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Eur J Pediatr (2006) 1.50
CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann N Y Acad Sci (2006) 1.47
Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med (1993) 1.42
Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol (2002) 1.35
The habitat, double life, citizenship, and forgetfulness of IgA. Immunol Rev (2012) 1.32
Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes (2006) 1.21
Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev (2005) 1.18
Unique regulation of CCL18 production by maturing dendritic cells. J Immunol (2003) 1.14
Toll-like receptor family and signalling pathway. Biochem Soc Trans (2000) 1.11
Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14. Blood (2009) 1.05
Activation of dendritic cells by toll-like receptors and C-type lectins. Handb Exp Pharmacol (2009) 1.00
Some active areas of DC research and their medical potential. Eur J Immunol (2010) 0.96
Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies. Respiration (1994) 0.92
A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells. Immunol Lett (2001) 0.83
Role of transcription factors in the pathogenesis of asthma and COPD. Cell Commun Adhes (2013) 0.83
Commentary on "Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic review". Eur J Pediatr (2007) 0.80
Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response. Mediators Inflamm (1994) 0.77